Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sale Of Pfizer’s Established Products Not Off The Table, Exec Says

This article was originally published in PharmAsia News

Executive Summary

Pfizer CFO Frank D’Amelio talks about the big pharma’s long-term vision and cost-reduction initiatives during the Morgan Stanley Healthcare conference. Management will continue reviewing the portfolio on an ongoing basis to see how best to maximize shareholder value, he said.

You may also be interested in...



Pfizer Moo’ved To Split Off Zoetis Business By July 2013

Pfizer begins the process to split off its animal health business with an IPO in an effort to save on taxes and refrain from diluting the current shareholder base.

Pfizer: Established Products And Consumer Health In; Animal Health And Nutrition Out

Pfizer takes a middle-of-the-road approach to breaking out non-core businesses, announcing plans to explore alternatives for Animal Health and Nutrition.

In Pfizer Business Review, Established Products Unit Is Most "Complex," Simmons Says

With Pfizer Inc. in the midst of a strategic business review that includes an evaluation of all business units outside the "innovative core," even the company's Established Products business unit - made up of mature pharmaceuticals that have lost exclusivity in developed markets - could be spun out or put up for sale

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC082180

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel